
Makdonic 25mg Injection
Marketer
Makcur Laboratories Ltd.
Salt Composition
Diclofenac (25mg)
Overview Makdonic 25mg Injection
Arthrocin 25mg Injection provides pain relief. This injectable medication addresses pain, inflammation, stiffness, and arthritic discomfort in conditions such as rheumatoid and osteoarthritis, plus acute musculoskeletal trauma. Parenteral administration is indicated when oral methods are unsuitable. Arthrocin 25mg Injection must be given by a qualified healthcare provider; self-injection is strictly prohibited. Patients with a history of cardiovascular events (heart disease or stroke) should disclose this to their physician. Report any injection site reactions (pain, swelling, redness) to your doctor immediately. Common adverse effects include nausea, vomiting, headache, and local injection site responses. For extended therapy, regular monitoring of renal and hepatic function, along with blood counts, may be necessary. Prolonged use carries potential risks of gastrointestinal bleeding and renal complications.
Primary Ingredients of Makdonic 25mg Injection
No text provided to rephrase.
Uses of Makdonic 25mg Injection
Analgesia
Major Benefits of Makdonic 25mg Injection:
This medication will be administered by your physician or their qualified associate; self-medication is strictly prohibited.
Common Side effects of Makdonic 25mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Makdonic 25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Makdonic 25mg Injection works:
Makdonic 25mg Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated swelling and redness.
SAFETY ADVICE
AlcoholCAUTION
Use of Makdonic 25mg Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Makdonic 25mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Administration of Makdonic 25mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administration of Makdonic 25mg Injection may impair driving ability due to potential adverse reactions.
KidneyCAUTION
Administering Makdonic 25mg Injection to individuals with impaired kidney function requires careful consideration. A modified dosage of Makdonic 25mg Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should use Makdonic 25mg Injection cautiously. Dosage modification of Makdonic 25mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Makdonic 25mg Injection :
Omit a Makdonic 25mg Injection dose? Seek your physician's advice.
Facts to Know About Makdonic 25mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylacetic Acid Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
